Company Filing History:
2 out of 1,744 
2 out of 6 
2 out of 280 
Years Active: 2016
Title: A Glimpse into the Innovations of Inventor Gwenael Cheve
Introduction: Gwenael Cheve, an accomplished inventor based in Montpellier, France, has made significant contributions to the fields of diagnostic and therapeutic methods through his innovative work. With two patents to his name, Cheve continues to push the boundaries of medical research with his pioneering ideas and inventions.
Latest Patents: Gwenael Cheve's most recent patents focus on anti-Axl antibodies used in diagnostic and therapeutic applications. His invention details a monoclonal antibody that exhibits specificity for Axl, featuring a heavy chain variable region with designated sequences in the H-CDR1, H-CDR2, and H-CDR3 regions. Similarly, the light chain variable region is characterized by specific sequences in the L-CDR1, L-CDR2, and L-CDR3 regions. This monoclonal antibody is engineered to bind to the extracellular domain of Axl, providing valuable insights into potential treatment methods.
Career Highlights: Throughout his career, Gwenael Cheve has worked with prominent research institutions and companies, including Inserm and the Institut National de la Santé et de la Recherche Médicale. Additionally, he has made substantial contributions while working at Oribase Pharma, further demonstrating his commitment to advancing medical innovation.
Collaborations: In his journey as an inventor, Cheve has collaborated with notable individuals such as Bruno Robert and Benedicte Fauvel. These partnerships have fostered a rich exchange of ideas and expertise, enhancing the scope and impact of his inventions.
Conclusion: Gwenael Cheve is a testament to the power of innovation in medicine. His work with anti-Axl antibodies showcases not only his ingenuity but also his dedication to improving diagnostic and therapeutic methods. With a bright future ahead, Cheve's contributions will undoubtedly continue to shape the landscape of medical research and innovation.